Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUNTIAM: Thiamine + Biotin for Huntington's Disease
NCT04478734Phase 2Recruiting
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Apr 2023
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of thiamine, biotin in Huntington disease (HD), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started Apr 2023; status: recruiting.
02
Drugs
thiaminebiotin
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on NCT04478734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04478734.